Fulgent Genetics Inc (FLGT)

Russell Investments Group Ltd. Sells 17133 Shares of Fulgent Genetics, Inc. (NASDAQ:FLGT) - Defense World

Defense World

Moffitt Cancer Center and Fulgent Pharma form a strategic partnership - Tampa Bay Business & Wealth - TBBW

TBBW

Moffitt and Fulgent Pharma partner on personalised cancer therapies - Yahoo Finance

Yahoo Finance

Moffitt and Fulgent partner on personalised cancer therapies - Pharmaceutical Technology

Pharmaceutical Technology

Moffitt Cancer Center and Fulgent Pharma Join Forces to Revolutionize Cancer Therapeutics - Business Wire

Business Wire

Is Fulgent Genetics (FLGT) Outperforming Other Medical Stocks This Year? - Yahoo Movies Canada

Yahoo Movies Canada

Trading (FLGT) With Integrated Risk Controls - Stock Traders Daily

Stock Traders Daily

Shareholders May Be Wary Of Increasing Fulgent Genetics, Inc.'s (NASDAQ:FLGT) CEO Compensation Package - Simply Wall St

Simply Wall St

UBS analysts initates a Neutral rating for Fulgent Genetics Inc (FLGT) – Knox Daily - Knox Daily

Knox Daily

Zurcher Kantonalbank Zurich Cantonalbank Increases Stake in Fulgent Genetics, Inc. (NASDAQ:FLGT) - Defense World

Defense World

Analysts Have Been Trimming Their Fulgent Genetics, Inc. (NASDAQ:FLGT) Price Target After Its Latest Report - Simply Wall St

Simply Wall St

Fulgent Genetics, Inc. (FLGT) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Canada Shine On

Yahoo Canada Shine On

Fulgent Genetics First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Simply Wall St

Simply Wall St

Fulgent Genetics, Inc. (NASDAQ:FLGT) Q1 2024 Earnings Call Transcript - Yahoo Finance

Yahoo Finance

Earnings call: Fulgent Genetics sees Q1 growth, targets higher margins - Investing.com Canada

Investing.com Canada

Earnings call: Fulgent Genetics sees Q1 growth, targets higher margins - Investing.com

Investing.com

Earnings call: Fulgent Genetics sees Q1 growth, targets higher margins - Investing.com India

Investing.com India

Fulgent Genetics, Inc. (FLGT) Reports Q1 Loss, Misses Revenue Estimates

Zacks Investment Research

Fulgent Genetics Inc (FLGT) Q1 2024 Earnings: Misses Analyst Forecasts with Wider Losses - GuruFocus.com

GuruFocus.com

Fulgent Genetics Releases Updated Investor Presentation - TipRanks.com - TipRanks

TipRanks

Fulgent Reports First Quarter 2024 Financial Results - Yahoo Finance

Yahoo Finance

Fulgent Genetics (NASDAQ:FLGT) Releases FY 2024 Earnings Guidance - MarketBeat

MarketBeat

American Well Corporation (AMWL) Reports Q1 Loss, Misses Revenue Estimates

Zacks Investment Research

Fulgent Genetics to Announce First Quarter 2024 Financial Results on Friday, May 3, 2024 - Business Wire

Business Wire

Fulgent Genetics Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance

Yahoo Finance

Fulgent Genetics Shares Business Insights in Investor Update - TipRanks.com - TipRanks

TipRanks

Privia Health (PRVA) Misses Q4 Earnings Estimates

Zacks Investment Research

Health Catalyst (HCAT) Q4 Earnings and Revenues Beat Estimates

Zacks Investment Research

Fulgent Genetics Stock: Buy Growth Ahead Below Liquidation Value (NASDAQ:FLGT) - Seeking Alpha

Seeking Alpha

Cooper Companies (COO), Fulgent Unite to Boost Genetic Testing - Yahoo Finance

Yahoo Finance

Cord Blood Registry® (CBR®) by CooperSurgical® and Fulgent Genetics Launch Innovative Genetic Testing - PR Newswire

PR Newswire

The 3 Best Digital Health Stocks for Personalized Medicine - InvestorPlace

InvestorPlace

Fulgent Genetics Inc (FLGT) Reports Q3 2023 Financial Results - Yahoo Finance

Yahoo Finance

Fulgent Genetics, Inc. (NASDAQ:FLGT) is definitely on the radar of institutional investors who own 47% of the company - Yahoo Finance

Yahoo Finance

Fulgent Moves Beyond Covid - Los Angeles Business Journal

Los Angeles Business Journal

Got $2,500? This Dirt Cheap Growth Stock Could Be Worth Buying Hand Over Fist - The Motley Fool

The Motley Fool

LA500 2023: Ming Hsieh - Los Angeles Business Journal

Los Angeles Business Journal

Fulgent Genetics Launches Mission Bio Platform to Broaden Accessibility of Single-Cell Multi-Omics for Drug ... - PR Newswire

PR Newswire

Global Carrier Screening Market to 2031: Players Include Fulgent Genetics, Illumina, Diasorin, Natera and Thermo ... - GlobeNewswire

GlobeNewswire

Fulgent Genetics Launches New Beacon787 Expanded Carrier Screening Panel - Business Wire

Business Wire

Fulgent Genetics facing class-action lawsuit after DOJ investigation - 2UrbanGirls

2UrbanGirls

Fulgent Genetics Now Being Investigated by DOJ - 209 Times

209 Times

Top 5 Best Genomics Stocks to Watch 2024 - Admiral Markets

Admiral Markets

Company files objection to mediation in Medicare fraud case - New Castle News

New Castle News

Company files objection to mediation in Medicare fraud case - New Castle News

New Castle News

1 Green Flag and 1 Red Flag for Fulgent Genetics After Earnings - The Motley Fool

The Motley Fool

Fulgent Makes Post-Covid Acquisition - Los Angeles Business Journal

Los Angeles Business Journal

Fulgent Genetics acquires therapeutics development firm Fulgent Pharma - Pharmaceutical Technology

Pharmaceutical Technology

Fulgent Genetics Acquires Fulgent Pharma, Creating a New Paradigm in Precision Medicine for The Company - Business Wire

Business Wire

Fulgent Genetics, Inc. Facing Class Action on Behalf of Investors Following Department of Justice Investigation into ... - PR Newswire

PR Newswire